Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

Despite not having a positive outcome, safety profiles for Keytruda and Lynparza were consistent with previous findings.

Source link
#Clinical #Trial #Keytruda #Lynparza #Combination #Fails #Meet #Primary #Endpoint #Treatment #Metastatic #Nonsquamous #NonSmall #Cell #Lung #Cancer